Clinical trial
Olanzapine Versus An Active Comparator in the Treatment of Schizophrenia
NCT00036088
Study timeline
Study start (unknown)2001-08-01Date precision: month
Registry last updated2006-07-19
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Schizophreniaunresolved
Interventions
OlanzapineDRUG · verified · RxNorm: olanzapine
Sponsors & collaborators
Eli Lilly and Companylead sponsor
Mapped research locations
New YorkNew York, United States1HoustonTexas, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1AtlantaGeorgia, United States1MiamiFlorida, United States1CincinnatiOhio, United States1PortlandOregon, United States1AustinTexas, United States1RichmondVirginia, United States1HamburgGermany1Buenos AiresArgentina1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00036088 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.